May 2022 - Downwards and onwards!
May has come and gone and so it is time for another entry in my investment journal. It has been quite an eventful month, although I have been busy with exams. The markets are still rough and both my portfolios continue to be in the red for the year. Unity (U) has taken a beating and suddenly Alphabet, the parent company of Google has found a place in my portfolio quicker than anticipated. Let us have a look!
April 2022 - It is not over yet
We made it through April... Barely. It has been the worst month in several years riddled with earnings disappointment and drama. Come check out what I feel about all this and how my portfolio is doing.
March 2022 - Back on track?
March is over and it is time for another entry in my investment journal. It has been a great month with a lot of action - so come along for an update on the good deals I have been able to pick up before market recovery, a brand new position, and lots of changes to my Watch List.
February 2022 - War in Europe
This is this second entry in my newly launched investment journal where I share my portfolio performance, moves, thoughts, and dividend history. The stock market continues its volatility amidst uncertainty and fear - and while the situation created by the Russian invasion of Ukraine has had an impact on my portfolio - it has not changed my strategy.
January 2022 - A tough start to the new year
Hi there! This is my first entry in my newly launched investment journal. I hope you like the new format! (if not, please tell me so)It has been a month of hardship as we have faced a market correction, but also one of opportunity for those who dare.
CRISPR - A gene editing technology to solve disease and an incredible growth opportunity
Breaking down what CRISPR is and how we can use it to solve disease. My case for CRISPR Therapeutics (CSPR) and my investment strategy.